Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
Institut Claudius Regaud
Columbia University
University of Alabama at Birmingham
Istituto Oncologico Veneto IRCCS
Travera Inc
Institut Mutualiste Montsouris
Assistance Publique - Hôpitaux de Paris
Novartis
Institut Claudius Regaud
The Christie NHS Foundation Trust
Charles University, Czech Republic
Dragonfly Therapeutics
Merck Sharp & Dohme LLC
Ipsen
Merck Sharp & Dohme LLC
Pfizer
Pfizer
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
Beth Israel Deaconess Medical Center
Philogen S.p.A.
Sun Yat-sen University
University Hospital, Lille
Bristol-Myers Squibb
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Kantonsspital Baden
CRISPR Therapeutics
Ankara University
Coherus Oncology, Inc.
Milton S. Hershey Medical Center
Dragonfly Therapeutics
MacroGenics
Arrowhead Pharmaceuticals
Goethe University
First Affiliated Hospital of Fujian Medical University
SWOG Cancer Research Network
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Assistance Publique - Hôpitaux de Paris
Leiden University Medical Center
Kazia Therapeutics Limited
Incyte Corporation
Institut Cancerologie de l'Ouest
Incyte Corporation
First Affiliated Hospital of Fujian Medical University
Australian and New Zealand Urogenital and Prostate Cancer Trials Group